Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|January 25, 2025
Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY studyLisa Mumford, Rachel Hogg, Adam Taylor, et al.
International Journal of Radiation Oncology, Biology, Physics|November 15, 2016
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell LymphomaLuca Ceriani, Maurizio Martelli, Maria K Gospodarowicz, et al.
British Journal of Haematology|February 6, 2016
Short duration immunochemotherapy followed by radioimmunotherapy consolidation is effective and well tolerated in relapsed follicular lymphoma: 5-year results from a UK National Cancer Research Institute Lymphoma Group studyTim M Illidge, Hayley S McKenzie, Sam Mayes, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 29, 2025
Association between COVID-19 vaccine immunogenicity and protection against infection and severe disease in clinically vulnerable patient populations: a systematic review and meta-analysis of observational studiesMaria Danysz, Rute Cardoso De Aguiar, Hema Pindolia, et al.
Biochemical Pharmacology|July 10, 2008
Characterisation of the in vitro activity of the depsipeptide histone deacetylase inhibitor spiruchostatin ASimon J Crabb, Melanie Howell, Helen Rogers, et al.
Communications Biology|March 15, 2022
Agonistic CD27 antibody potency is determined by epitope-dependent receptor clustering augmented through Fc-engineeringFranziska Heckel, Anna H Turaj, Hayden Fisher, et al.
Leukemia|August 1, 2023
XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expressionJack G Fisher, Amber D P Doyle, Lara V Graham, et al.
British Journal of Haematology|August 2, 2016
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trialMary Gleeson, Eliza A Hawkes, David Cunningham, et al.
The American Journal of Pathology|January 1, 2003
Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulinsStefano A Pileri, Gianluca Gaidano, Pier Luigi Zinzani, et al.
Blood|June 20, 2015
Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphomaLuca Ceriani, Maurizio Martelli, Pier Luigi Zinzani, et al.
Pageof 11